Malaria Consortium established an office in Ouagadougou, the capital of Burkina Faso, in December 2014 as part of its ACCESS-SMC project. Malaria is highly seasonal in Burkina Faso, with an estimated 60 percent of malaria cases occurring between July and November. Seasonal malaria chemoprevention (SMC) is one method that prevents malaria in children from 3 to 59 months (who are the most at risk of contracting the disease) during the rainy season. ACCESS-SMC was a UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services, to bring SMC to seven countries across the Sahel in order to reduce malaria transmission. Through other funding streams, Malaria Consortium will continue to ensure that children protected under the project receive SMC and work to reach more eligible children living in Burkina Faso.
 

Our area of focus in Burkina Faso includes: